What is the current revenue of the digital diabetes management market?

The market revenue for digital diabetes management is anticipated at USD 16.7 billion in 2027.

How much is the digital diabetes management industry expected to grow by 2036?

Digital Diabetes Management Market size stood at USD 15.5 billion in 2026 and is predicted to grow at a 9.22% CAGR from 2027 to 2036, surpassing USD 37.44 billion by 2036.

How is rising diabetes prevalence influencing adoption of connected monitoring in the Digital Diabetes Management Market?

Increasing diabetes prevalence is accelerating adoption of continuous glucose monitoring and wearable systems, shifting care toward real-time data-driven management. This supports improved adherence, earlier intervention, and greater reliance on interoperable connected devices in long-term care routines.

How are AI and telemedicine reshaping care delivery models in the Digital Diabetes Management Market?

AI-enabled systems enhance glucose data interpretation through predictive insights and personalized treatment support, while telemedicine integration enables continuous remote monitoring. Together, they improve clinical responsiveness and reduce dependency on in-person consultations.

Why do Hospitals represent the largest end-use segment in the digital diabetes management market?

Hospitals accounted for 43.99% of the market in 2026 due to their central role in structured monitoring, coordinated diabetes care, and integration of digital tools into broader patient management systems.

Why are Home Settings emerging as the fastest-growing end-use segment in digital diabetes management?

Home Settings are expanding quickly as connected monitoring solutions enable convenient self-management and continuous glucose tracking, making routine diabetes care increasingly practical outside traditional clinical environments.

What makes North America the leading region in digital diabetes management?

North America accounted for a 40.49% share in 2026, supported by connected monitoring adoption, digital health platforms, and integrated chronic care workflows.

How is Asia Pacific creating new opportunities in digital diabetes management?

Asia Pacific is expected to grow at a 9.49% CAGR as healthcare systems adopt scalable digital tools, remote monitoring, and app-based diabetes support.

Which companies are driving growth in the digital diabetes management landscape?

Top players in the digital diabetes management market include Abbott Laboratories (United States), Medtronic plc (Ireland), DexCom, Inc. (United States), F. Hoffmann-La Roche Ltd (Switzerland), PHC Holdings Corporation (Ascensia Diabetes Care Holdings AG) (Japan), Insulet Corporation (United States), LifeScan, Inc. (United States), Sanofi S.A. (France), B. Braun Melsungen AG (Germany).